← Eichor
Study identifier: NCT05336357 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non-invasive Goal-directed thErapy oN cIrcUlatory Shock

Condition: Hemodynamics Instability  ·  Sponsor: University of Sao Paulo

PhaseNA
Planned participants380
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Circulatory shock occurs when the oxygen supply to the tissues decreases, leading to cellular damage and affecting about one-third of patients admitted to Intensive Care Units (ICUs). Cardiac Output (CO) is defined as the volume of blood ejected by the left ventricle per minute and is a crucial hemodynamic parameter for monitoring patients with signs of circulatory shock. However, this parameter is underutilized in patients treated in Emergency Units because its measurement typically involves invasive methods, which are not commonly available in this setting. Any method capable of measuring CO without the need for pulmonary artery catheter insertion is referred to as minimally invasive CO monitoring. Evaluating these parameters allows for a quicker determination of the etiology of circulatory shock, enabling the early initiation of goal-directed therapy. Goal-directed therapy has been proven effective in reducing morbidity and mortality, ICU length of stay, and mechanical ventilation duration in ICU patients who respond to fluid resuscitation. Currently, there are no data on the impact of a hemodynamic optimization strategy in patients during the early hours of shock. The objective is to assess whether goal-directed hemodynamic therapy, through non-invasive hemodynamic monitoring, reduces the time required for hemodynamic resuscitation in patients with septic shock. A multicenter, randomized, open-label study will be conducted in Emergency Units, Intensive Care Units, and Ho…

This description comes directly from the study's public registry record.

Talk to the study team

Ludhmila A Hajjar, MD, PhD  ·  +55 11 26615795  ·  ludhmila@usp.br

ARO F InCor, MD  ·  +55 11 26615795  ·  aro@incor.usp.br

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto do CoraçãoSão Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05336357